한글목차

세계 디지털 유방 토모신세시스 장비 시장의 미래는 병원 및 진단 센터 시장에서의 기회로 인해 유망합니다. 세계 디지털 유방 토모신세시스 장비 시장은 2025년부터 2031년까지 14.2%의 CAGR로 2031년까지 약 122억 달러에 달할 것으로 예상됩니다. 이 시장의 주요 촉진요인은 고령화 인구의 급격한 증가, 디지털 유방 토모신세시스 장비의 지속적인 기술 발전, 유방암 검진에 대한 인식의 증가입니다.

• Lucintel에 따르면, 제품 유형별로는 디지털 유방 토모신세시스 장비 분야의 기술 개발로 인해 예측 기간 동안 장비가 계속해서 큰 비중을 차지할 것으로 예측했습니다.
• 최종 용도별로는 유방암 유병률 증가와 호흡곤란, 통증, 메스꺼움을 호소하는 암 환자들의 병원 선호도가 높아짐에 따라 병원이 가장 큰 시장으로 부상할 것으로 예상됩니다.
• 지역별로는 아시아태평양이 유방암 발병률 증가와 의료 인프라 개선으로 인해 예측 기간 동안 가장 높은 성장세를 보일 것으로 예상됩니다.

디지털 유방 토모신세시스 장비 시장의 전략적 성장 기회

디지털 유방 토모신세시스 장비 시장은 빠르게 발전하고 있으며, 영상 기술의 발전과 유방암 발견 향상에 대한 수요 증가로 인해 다양한 응용 분야에서 큰 성장 기회를 창출하고 있습니다. 디지털 유방 토모신세시스는 유방 조직의 3D 뷰를 제공하여 진단 정확도를 높이고 위양성을 감소시킵니다. 응용 분야 확대, 환자 결과 개선, 접근성 향상을 위한 혁신으로 인해 이 기술이 임상에 더 많이 통합되어 전략적 성장 기회를 창출하고 있습니다. 아래에서는 디지털 유방 토모신세시스 장비 시장의 5가지 주요 성장 기회를 개략적으로 살펴보고, 이러한 애플리케이션이 어떻게 시장 확대를 촉진할 수 있는지에 대해 강조합니다.

• 진단 정확도 향상 : 디지털 유방 토모신세시스 기술은 기존 2D 유방촬영술에 비해 진단 정확도가 크게 향상되었습니다. 유방 조직을 3차원적으로 볼 수 있기 때문에 중첩된 구조를 더 잘 구별하고 작은 종양이나 밀집된 종양을 식별하는 데 도움이 됩니다. 기술이 발전함에 따라 이미지의 해상도를 더욱 높이고 고급 알고리즘을 통합하여 조기 유방암의 검출률을 향상시킬 수 있는 기회가 있습니다. 이러한 성장 기회는 특히 유방암 발병률이 높은 지역에서 진단 도구의 개선이 환자 예후에 큰 영향을 미치는 지역과 관련이 있습니다.
• 인공지능(AI)과의 통합 : 디지털 유방 토모신세시스 시스템에 AI를 통합하는 것은 영상 분석 및 판독을 강화함으로써 큰 성장 기회가 될 수 있으며, AI 알고리즘은 이상 감지 자동화, 긴급성에 기반한 사례 우선순위 지정, 의사결정 지원 등을 통해 영상의학과 전문의에게 도움을 줄 수 있습니다. 이러한 통합은 진단 과정을 가속화할 뿐만 아니라, 일반적으로 놓칠 수 있는 우려 영역을 강조함으로써 정확도를 향상시킬 수 있습니다. 디지털 유방 토모신세시스 시스템에서 AI 기능의 확대는 조기 발견과 개인화된 치료 계획의 획기적인 발전을 촉진할 것으로 예상됩니다.
• 신흥 시장으로의 확장 : 의료 투자 증가와 유방암 검진에 대한 인식이 높아지면서 디지털 유방 토모신세시스 기술을 신흥 시장으로 확장할 수 있는 기회가 증가하고 있습니다. 비용 효율적인 솔루션 제공, 현지 의료 서비스 제공자와의 제휴 등 디지털 유방 토모신세시스 시스템을 해당 지역의 특성에 맞게 조정함으로써 시장 진입과 성장을 촉진할 수 있습니다. 이러한 확장은 의료 서비스가 부족한 지역의 유방암 발견율을 높이는 데 매우 중요하며, 첨단 진단 기술에 대한 접근성을 높이기 위한 세계 보건 이니셔티브에 부합하는 것입니다.
• 하이브리드 영상 시스템 : 디지털 유방 토모신세스와 초음파 및 MRI와 같은 다른 영상 진단 시스템을 결합한 하이브리드 영상 진단 시스템의 개발은 큰 성장 기회가 될 것입니다. 이러한 통합 시스템은 다양한 영상 기술의 장점을 결합하여 종합적인 진단 능력을 제공합니다. 예를 들어, 하이브리드 시스템은 유방 디지털 촬영에서 얻은 상세한 해부학적 정보와 초음파 검사에서 얻은 기능적 인사이트를 동시에 제공하여 병변의 특성화 및 진단 정확도를 높일 수 있습니다. 이러한 추세는 유방암 검진에 대한 보다 종합적인 접근을 지원하여 환자 관리와 결과를 개선할 수 있도록 돕습니다.
• 환자 중심 기능의 중요성 : 유방 디지털 토모신세시스 시스템의 환자 중심 기능에 투자함으로써 환자 경험과 순응도를 향상시키고 성장을 촉진할 수 있습니다. 최근 혁신에는 보다 부드러운 압박 패들, 자동 포지셔닝 시스템, 검사 중 불편함을 최소화하는 사용자 친화적인 인터페이스 등이 포함됩니다. 환자의 편안함을 높이는 것은 정기적인 검진을 장려하고 유방촬영술에 대한 불안감을 줄이는 데 매우 중요합니다. 환자 중심의 설계가 우선시되는 가운데, 시장에서 제품을 차별화하고 더 나은 환자 경험을 제공하는 데 중점을 두는 의료 시설에 어필할 수 있는 기회가 있습니다.

디지털 유방 토모신세시스 시장은 다양한 응용 분야에서 전략적 성장을 이룰 수 있는 위치에 있습니다. 진단 정확도 향상, AI 통합, 신흥 시장 진출, 하이브리드 영상 처리 시스템 개발, 환자 중심 기능 중심 등의 개발 기회가 유방암 검진의 미래를 형성하고 있습니다. 이러한 성장 기회를 활용하면 조기 발견의 발전, 환자 예후 개선, 디지털 유방 토모신세시스 기술의 전 세계 보급을 촉진할 수 있습니다.

디지털 유방 토모신세시스 장비 시장 촉진요인 및 과제

디지털 유방 토모신세시스 장비 시장은 다양한 기술적, 경제적, 규제적 요인의 영향을 받고 있으며, 이러한 요인들이 시장 성장을 촉진하고 도전과제로 작용하고 있습니다. 디지털 유방 토모신세시스 기술이 발전함에 따라 유방암 탐지 및 진단 정확도 향상에 대한 주요 수요를 충족시킬 수 있을 것입니다. 그러나 시장은 높은 비용, 통합 문제, 규제의 복잡성 등의 장애물에 직면해 있습니다. 이러한 촉진요인과 과제를 이해하는 것은 진화하는 유방 영상 기술의 미래를 개척하고자 하는 이해관계자들에게 매우 중요합니다.

디지털 유방 토모신세시스 장비 시장을 주도하는 요인은 다음과 같습니다:

• 기술 발전 : 영상 기술의 발전은 디지털 유방 토모신세시스 시장의 성장을 크게 촉진할 것입니다. 이미지 해상도 향상, 검출기 기술 개선, 고급 재구성 알고리즘은 보다 정확하고 상세한 유방 영상 진단에 기여하고 있습니다. 이러한 기술적 개선으로 고밀도 유선 조직과 작은 병변을 더 잘 볼 수 있게 되어 진단 정확도가 향상되고 있습니다. 자동분석을 위한 AI를 내장하는 등 영상처리 기술의 지속적인 연구 개발은 임상 현장에서 디지털 유방 토모신세시스 시스템의 채택을 더욱 촉진하고 유방암의 조기 발견율을 향상시킬 것입니다.
• 조기 발견에 대한 수요 증가 : 유방암 조기 발견의 중요성에 대한 인식이 높아짐에 따라 디지털 유방 토모신세시스 장비 시장의 주요 촉진요인으로 작용하고 있습니다. 전 세계적으로 유방암 발병률이 증가함에 따라 보다 정확하고 신뢰할 수 있는 결과를 제공하는 첨단 진단 도구에 대한 수요가 증가하고 있습니다. 디지털 유방 토모신세시스는 위양성을 줄이고 중첩된 구조를 더 잘 구별할 수 있기 때문에 환자와 의료진 모두에게 매력적인 선택이 되고 있습니다. 이러한 조기 및 정확한 검출에 대한 수요 증가는 디지털 유방 토모신세시스 시스템의 시장 성장과 채택을 촉진하고 있습니다.
• 정부 및 의료 정책 : 유방암 검진 및 조기 발견을 촉진하기 위한 정부의 노력과 의료 정책이 디지털 유방 토모신세시스 시장을 주도하고 있습니다. 정기적인 유방 촬영 검진을 지원하고 첨단 진단 기술에 대한 재정 지원을 제공하는 프로그램은 디지털 유방 토모신세시스 시스템에 대한 접근성을 확대할 것입니다. 또한, 특정 환자 그룹에 대한 디지털 유방 토모신세시스 사용을 권장하거나 의무화하는 이니셔티브는 시장 성장을 더욱 촉진할 수 있습니다. 이러한 정책은 디지털 유방 토모신세시스 장비의 채택을 증가시킬 뿐만 아니라 환자의 예후를 개선하고 말기 암 치료와 관련된 의료 비용을 절감하는 데에도 기여할 것입니다.
• 인공지능(AI)과의 통합 : 디지털 유방 토모신세시스 장비에 AI를 통합하여 진단 능력을 향상시키고 시장 성장을 촉진하며, AI 알고리즘은 자동 이미지 분석을 지원하여 종양 검출의 정확도를 높이고 방사선과 의사의 업무 부담을 줄입니다. 이러한 기술 발전은 더 빠르고 정확한 진단을 지원하고 더 나은 환자 관리로 이어집니다. 또한, AI의 도입은 의사결정 지원 및 사례의 우선순위를 지정하여 방사선과 의사 부족에 대응하고, 의료 시설에서 디지털 유방 토모신세시스 장비의 도입 증가를 촉진하는 중요한 요인으로 작용하고 있습니다.
• 환자의 편안함과 경험의 중요성 : 환자의 편안함과 경험의 개선은 첨단 디지털 유방 초음파 장비의 채택을 촉진하고 있습니다. 보다 부드러운 압박 패들, 자동 포지셔닝, 사용자 친화적인 인터페이스와 같은 기술 혁신은 검진 중 환자의 불편함과 불안을 줄여줍니다. 개선된 환자 경험은 권장 검진 준수율을 높이고 전반적인 만족도를 향상시킬 수 있습니다. 환자의 우려를 해결하고 프로세스를 보다 편안하게 만들어 시장 진입자와 의료 기업은 더 많은 여성들이 정기적인 유방암 검진에 참여하도록 유도하여 시장 성장을 촉진할 수 있습니다.

디지털 유방 토모신세시스 장비 시장의 과제는 다음과 같습니다:

• 높은 장비 비용 : 디지털 유방 토모신세시스 장비의 높은 가격은 여전히 시장 성장에 큰 걸림돌로 작용하고 있습니다. 고도의 영상처리 기술과 정교한 기능이 디지털 유방 토모신세시스 장비의 높은 가격의 원인으로 작용하고 있으며, 특히 소규모 의료 시설과 신흥 시장에서는 도입 장벽으로 작용할 수 있습니다. 디지털 유방 토모신세시스 장비의 구매 및 유지보수에 많은 투자가 필요하기 때문에 접근성이 제한되어 이러한 첨단 시스템의 보급이 늦어질 수 있습니다. 이 문제를 극복하기 위해서는 비용 문제를 해결하고 보다 비용 효율적인 솔루션을 개발하는 것이 중요합니다.
• 기존 시스템과의 통합 : 디지털 유방 토모신세시스 시스템을 기존 영상 진단 인프라 및 전자 의료 기록(EHR)과 통합하는 것은 복잡하고 어려운 과제입니다. 새로운 디지털 유방 토모신세시스 기술과 기존 시스템 간의 호환성 문제로 인해 소프트웨어 및 하드웨어 업그레이드에 추가 투자가 필요할 수 있습니다. 원활한 워크플로우와 정확한 데이터 공유를 보장하기 위해서는 효과적인 통합이 필수적입니다. 이러한 통합 문제를 극복하기 위해서는 다양한 의료 환경에서 디지털 유방 토모신세시스 시스템의 원활한 도입과 활용을 촉진하기 위한 기술적, 운영적 장애물을 해결해야 합니다.
• 규제 및 컴플라이언스 문제 : 디지털 유방 토모신세시스 시장에서 규제 요건과 컴플라이언스 문제 해결은 중요한 과제입니다. 국가마다 의료장비 관련 규제가 다르기 때문에 디지털 유방 토모신세시스 시스템의 승인 및 판매에 영향을 미칠 수 있습니다. 유방 디지털 토모신세시스 장비가 안전성, 유효성, 성능에 대한 엄격한 기준을 충족하는지 확인하는 것은 매우 중요하지만, 시간과 비용이 많이 소요될 수 있습니다. 제조업체는 규제 변화에 지속적으로 대응하고 규제 당국과 긴밀하게 협력하여 승인 절차를 간소화하고 시장 진입을 촉진해야 합니다.

디지털 유방 토모신세시스 시장은 기술 발전, 조기 발견에 대한 수요 증가, 정부 지원책, AI 통합, 환자 편의성 중시 등의 영향을 받고 있습니다. 그러나 고가의 장비 비용, 통합 문제, 규제 장애물 등의 과제를 해결해야 합니다. 이해관계자들이 시장을 효과적으로 탐색하고 잠재적인 장애물을 극복하면서 성장 기회를 활용하기 위해서는 이러한 촉진요인과 과제를 이해하는 것이 필수적입니다.

목차

제1장 주요 요약

제2장 세계의 디지털 유방 토모신세시스 장비 시장 : 시장 역학

• 소개, 배경, 분류
• 공급망
• 업계 성장 촉진요인과 과제

제3장 시장 동향과 예측 분석(2019-2031년)

• 거시경제 동향(2019-2024년)과 예측(2025-2031년)
• 세계의 디지털 유방 토모신세시스 장비 시장 동향(2019-2024년)과 예측(2025-2031년)
• 세계의 디지털 유방 토모신세시스 장비 시장 : 제품 종류별
  • 장비
  • 업그레이드
• 세계의 디지털 유방 토모신세시스 장비 시장 : 최종 용도별
  • 병원
  • 진단 센터
  • 기타

제4장 지역별 시장 동향과 예측 분석(2019-2031년)

• 세계의 디지털 유방 토모신세시스 장비 시장 : 지역별
• 북미의 디지털 유방 토모신세시스 장비 시장
• 유럽의 디지털 유방 토모신세시스 장비 시장
• 아시아태평양의 디지털 유방 토모신세시스 장비 시장
• 기타 지역의 디지털 유방 토모신세시스 장비 시장

제5장 경쟁 분석

• 제품 포트폴리오 분석
• 운영 통합
• Porter's Five Forces 분석

제6장 성장 기회와 전략 분석

• 성장 기회 분석
  • 세계의 디지털 유방 토모신세시스 장비 시장 성장 기회 : 제품 종류별
  • 세계의 디지털 유방 토모신세시스 장비 시장 성장 기회 : 최종 용도별
  • 세계의 디지털 유방 토모신세시스 장비 시장 성장 기회 : 지역별
• 세계의 디지털 유방 토모신세시스 장비 시장 최신 동향
• 전략적 분석
  • 신제품 개발
  • 세계의 디지털 유방 토모신세시스 장비 시장 생산능력 확대
  • 세계의 디지털 유방 토모신세시스 장비 시장 기업 인수합병(M&A), 합작투자
  • 인증과 라이선싱

제7장 주요 기업 개요

• Hologic
• GE Healthcare
• Siemens Healthineers
• Dexela
• Fujifilm
• Planmed OY
• Trivitron Healthcare

영문목차

The future of the global digital breast tomosynthesis equipment market looks promising with opportunities in the hospital, and diagnostic center markets. The global digital breast tomosynthesis equipment market is expected to reach an estimated $12.2 billion by 2031 with a CAGR of 14.2% from 2025 to 2031. The major drivers for this market are the surging aging population, ongoing technological advancement digital breast tomosynthesis equipment, and rising awareness about breast cancer screening.

• Lucintel forecasts that, within the product type category, equipment will remain a larger segment over the forecast period due to technological developments in the field of digital breast tomosynthesis equipment.
• Within the end use category, hospitals will remain the largest segment due to the rising prevalence of breast cancer and the increasing preference of cancer patients towards hospitals who are undergoing shortness of breath, pain, and nausea.
• In terms of regions, APAC is expected to witness the highest growth over the forecast period due to growing breast cancer incidence and improvements in the healthcare infrastructure in the region.

Gain Valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Digital Breast Tomosynthesis Equipment Market

The digital breast tomosynthesis equipment market is evolving rapidly, driven by technological advancements and increasing demand for improved breast cancer screening and diagnosis. DBT, or 3D mammography, enhances the accuracy of breast imaging by providing a detailed, three-dimensional view of breast tissue, which helps in early detection and reducing false positives. As technology progresses, several emerging trends are shaping the market, including advancements in image quality, integration with artificial intelligence, and expanding applications. These trends reflect the ongoing innovation and growth within the digital breast tomosynthesis sector, addressing clinical needs and improving patient outcomes.

• Integration of Artificial Intelligence: The integration of AI into digital breast tomosynthesis systems is a significant trend, enhancing image analysis and diagnostic accuracy. AI algorithms assist radiologists by automatically identifying potential abnormalities, reducing reading time, and improving detection rates. Recent developments include AI tools that aid in distinguishing between benign and malignant lesions, offering decision support and reducing the likelihood of false positives. This technology also helps in prioritizing cases based on urgency, thereby streamlining workflow and enhancing overall efficiency in breast cancer screening.
• Advancements in Image Resolution and Quality: Technological advancements are leading to improvements in image resolution and quality for digital breast tomosynthesis systems. Newer models feature higher spatial resolution and contrast, allowing for clearer and more detailed images of breast tissue. This enhancement helps in better visualization of small or dense tumors and reduces the likelihood of missed diagnoses. Innovations include advanced detector technologies and optimized reconstruction algorithms, which contribute to more precise imaging and improved diagnostic confidence for radiologists.
• Hybrid Imaging Systems: The development of hybrid imaging systems that combine digital breast tomosynthesis with other modalities, such as ultrasound or MRI, is gaining traction. These systems provide comprehensive breast imaging solutions by integrating complementary diagnostic technologies. Hybrid systems offer the advantage of combining detailed 3D imaging with additional functional or structural information, improving overall diagnostic accuracy and enabling better treatment planning. This trend reflects a shift towards more holistic approaches in breast cancer diagnosis and management.
• Increased Focus on Patient Comfort: Enhancements aimed at increasing patient comfort during digital breast tomosynthesis procedures are becoming a key trend. Newer digital breast tomosynthesis systems are designed to minimize discomfort and reduce examination time, addressing common patient concerns. Innovations include softer compression paddles, automated positioning systems, and improved ergonomics to enhance the patient experience. These advancements aim to encourage higher patient compliance with screening recommendations and make the diagnostic process less invasive and more patient-friendly.
• Expansion into Emerging Markets: The digital breast tomosynthesis market is expanding into emerging markets with increasing investments and installations in regions such as Asia-Pacific and Latin America. Efforts are focused on making digital breast tomosynthesis technology more accessible and affordable in these regions, where there is a growing demand for advanced breast imaging solutions. Partnerships with local distributors and healthcare providers, along with tailored product offerings, are helping to address the needs of these emerging markets and improve breast cancer detection rates globally.

The digital breast tomosynthesis equipment market is experiencing dynamic changes driven by technological innovations and a growing emphasis on improving breast cancer diagnosis. Emerging trends such as AI integration, enhanced image quality, hybrid imaging systems, patient comfort improvements, and market expansion into emerging regions are shaping the future of digital breast tomosynthesis. These developments are enhancing diagnostic accuracy, patient experience, and accessibility, reflecting a broader commitment to advancing breast cancer care and early detection.

Recent Developments in the Digital Breast Tomosynthesis Equipment Market

Recent developments in the digital breast tomosynthesis equipment market reflect a period of rapid innovation and improvement. As digital breast tomosynthesis continues to gain prominence in breast cancer screening and diagnosis, advancements are emerging that enhance imaging capabilities, patient experience, and integration with other technologies. These developments are driven by ongoing research, technological advancements, and a heightened focus on improving diagnostic accuracy and accessibility. The following outlines five key recent developments in the digital breast tomosynthesis equipment market.

• Enhanced Image Resolution and Quality: New digital breast tomosynthesis systems are incorporating advanced detector technologies and imaging algorithms to significantly improve image resolution and quality. Innovations such as higher spatial resolution detectors and optimized reconstruction techniques enable clearer, more detailed images of breast tissue. These advancements help in better visualizing small or dense tumors, thus improving diagnostic accuracy and reducing the rate of false positives. Enhanced image quality supports radiologists in making more precise assessments and helps in the early detection of breast cancer.
• Integration of Artificial Intelligence (AI): AI integration in digital breast tomosynthesis systems is becoming increasingly prevalent, offering tools that assist in automated image analysis and interpretation. AI algorithms are designed to detect abnormalities, prioritize cases, and provide decision support, reducing the workload on radiologists and enhancing diagnostic efficiency. These systems can help identify subtle lesions that may be missed by the human eye and offer predictive analytics based on large datasets, contributing to improved early detection and treatment planning.
• Development of Hybrid Imaging Systems: Hybrid imaging systems that combine digital breast tomosynthesis with other modalities, such as ultrasound or MRI, are emerging as a significant trend. These systems provide a more comprehensive approach to breast imaging by integrating the strengths of multiple diagnostic technologies. For example, combining digital breast tomosynthesis with ultrasound can enhance lesion characterization and provide additional functional information. This integrated approach improves overall diagnostic accuracy and supports better clinical decision-making.
• Advancements in Patient Comfort: Recent digital breast tomosynthesis systems are designed with a greater focus on patient comfort. Innovations include softer compression paddles, automated positioning systems, and user-friendly interfaces that reduce discomfort and anxiety during the examination. These advancements aim to make the screening process less invasive and more pleasant for patients, which can lead to higher screening compliance and better patient experiences. Enhanced comfort features are particularly important in encouraging regular mammography screenings.
• Expansion and Accessibility in Emerging Markets: The digital breast tomosynthesis equipment market is expanding into emerging markets, driven by increased investments and efforts to make advanced breast imaging more accessible globally. Companies are working to adapt digital breast tomosynthesis technology to the specific needs and conditions of these regions, including cost-effective solutions and local partnerships. This expansion aims to improve breast cancer detection rates in areas with growing healthcare infrastructure and increasing awareness of the benefits of early screening.

Recent developments in the digital breast tomosynthesis equipment market highlight significant advancements in imaging technology, AI integration, patient comfort, and global accessibility. These improvements are transforming breast cancer screening and diagnosis, enhancing both the accuracy of detection and the overall patient experience. As technology continues to evolve, the digital breast tomosynthesis market is poised to offer even more sophisticated solutions for early breast cancer detection and effective clinical management.

Strategic Growth Opportunities for Digital Breast Tomosynthesis Equipment Market

The digital breast tomosynthesis equipment market is evolving rapidly, offering significant growth opportunities across various applications due to advancements in imaging technology and increasing demand for improved breast cancer detection. Digital breast tomosynthesis provides a 3D view of breast tissue, enhancing diagnostic accuracy and reducing false positives. Strategic growth opportunities are emerging as the technology becomes more integrated into clinical practice, with innovations aimed at expanding applications, improving patient outcomes, and increasing accessibility. The following outlines five key growth opportunities within the digital breast tomosynthesis equipment market, highlighting how these applications are poised to drive market expansion.

• Enhanced Diagnostic Accuracy: digital breast tomosynthesis technology offers significant improvements in diagnostic accuracy compared to traditional 2D mammography. The ability to view breast tissue in three dimensions helps in better distinguishing between overlapping structures and identifying small or dense tumors. As technology advances, there are opportunities to further enhance image resolution and incorporate advanced algorithms to improve detection rates for early-stage breast cancer. This growth opportunity is particularly relevant in regions with high breast cancer incidence, where improved diagnostic tools can significantly impact patient outcomes.
• Integration with Artificial Intelligence (AI): The integration of AI into digital breast tomosynthesis systems represents a major growth opportunity by enhancing image analysis and interpretation. AI algorithms can assist radiologists by automating the detection of abnormalities, prioritizing cases based on urgency, and providing decision support. This integration not only speeds up the diagnostic process but also improves accuracy by highlighting areas of concern that might otherwise be missed. The expansion of AI capabilities in digital breast tomosynthesis systems is expected to drive significant advancements in early detection and personalized treatment plans.
• Expansion into Emerging Markets: There is a growing opportunity to expand digital breast tomosynthesis technology into emerging markets, where increasing healthcare investments and rising awareness about breast cancer screening are creating demand. Tailoring digital breast tomosynthesis systems to meet the specific needs of these regions, such as offering cost-effective solutions and partnering with local healthcare providers, can facilitate market entry and growth. This expansion is crucial for improving breast cancer detection rates in underserved areas and aligns with global health initiatives aimed at increasing access to advanced diagnostic technologies.
• Hybrid Imaging Systems: Developing hybrid imaging systems that combine digital breast tomosynthesis with other modalities, such as ultrasound or MRI, presents a significant growth opportunity. These integrated systems offer comprehensive diagnostic capabilities by combining the strengths of various imaging technologies. For instance, a hybrid system can provide detailed anatomical information from digital breast tomosynthesis alongside functional insights from ultrasound, enhancing lesion characterization and diagnostic accuracy. This trend supports a more holistic approach to breast cancer screening and can lead to better patient management and outcomes.
• Focus on Patient-Centric Features: Investing in patient-centric features in digital breast tomosynthesis systems can drive growth by improving patient experience and compliance. Recent innovations include softer compression paddles, automated positioning systems, and user-friendly interfaces that minimize discomfort during exams. Enhancing patient comfort is crucial for encouraging regular screenings and reducing anxiety associated with mammography. As patient-centric designs become a priority, there is an opportunity to differentiate products in the market and appeal to healthcare facilities focused on providing a better patient experience.

The digital breast tomosynthesis equipment market is positioned for strategic growth across various applications. Opportunities to enhance diagnostic accuracy, integrate AI, expand into emerging markets, develop hybrid imaging systems, and focus on patient-centric features are shaping the future of breast cancer screening. Leveraging these growth opportunities can drive advancements in early detection, improve patient outcomes, and broaden the reach of digital breast tomosynthesis technology globally.

Digital Breast Tomosynthesis Equipment Market Driver and Challenges

The digital breast tomosynthesis equipment market is influenced by a range of technological, economic, and regulatory factors that drive its growth and present challenges. As digital breast tomosynthesis technology advances, it addresses key demands for improved breast cancer detection and diagnostic accuracy. However, the market also faces hurdles such as high costs, integration issues, and regulatory complexities. Understanding these drivers and challenges is crucial for stakeholders aiming to navigate the evolving landscape of breast imaging technology.

The factors responsible for driving the digital breast tomosynthesis equipment market include:

• Technological Advancements: Advances in imaging technology significantly drive the growth of the digital breast tomosynthesis market. Enhanced image resolution, improved detector technologies, and sophisticated reconstruction algorithms contribute to more accurate and detailed breast imaging. These technological improvements enable better visualization of dense breast tissue and small lesions, thereby enhancing diagnostic accuracy. Continuous research and development in imaging techniques, such as incorporating AI for automated analysis, further drive the adoption of digital breast tomosynthesis systems in clinical settings, improving early detection rates of breast cancer.
• Increased Demand for Early Detection: Growing awareness about the importance of early breast cancer detection is a major driver for the digital breast tomosynthesis equipment market. With increasing incidences of breast cancer globally, there is a rising demand for advanced diagnostic tools that provide more precise and reliable results. Digital breast tomosynthesis capability to reduce false positives and better differentiate between overlapping structures makes it an attractive option for both patients and healthcare providers. This heightened demand for early and accurate detection propels the market growth and adoption of digital breast tomosynthesis systems.
• Government and Healthcare Initiatives: Government initiatives and healthcare policies promoting breast cancer screening and early detection drive the digital breast tomosynthesis market. Programs that support regular mammography screenings and help funding for advanced diagnostic technologies expand access to digital breast tomosynthesis systems. Additionally, initiatives that recommend or mandate the use of digital breast tomosynthesis for specific patient groups further boost market growth. Such policies not only increase the adoption of digital breast tomosynthesis equipment but also contribute to improved patient outcomes and reduced healthcare costs related to late-stage cancer treatment.
• Integration with Artificial Intelligence (AI): The integration of AI in digital breast tomosynthesis systems enhances diagnostic capabilities and drives market growth. AI algorithms assist in automated image analysis, improving the accuracy of tumor detection and reducing radiologists' workload. This technological advancement supports faster and more accurate diagnoses, leading to better patient management. The incorporation of AI also addresses the shortage of radiologists by providing decision support and prioritizing cases, making it a significant driver for the increased adoption of digital breast tomosynthesis equipment in medical facilities.
• Focus on Patient Comfort and Experience: Enhancements in patient comfort and experience are driving the adoption of advanced digital breast tomosynthesis systems. Innovations such as softer compression paddles, automated positioning, and user-friendly interfaces reduce patient discomfort and anxiety during screenings. Improved patient experience leads to higher compliance with recommended screenings and better overall satisfaction. By addressing patient concerns and making the process more comfortable, manufacturers and healthcare providers can encourage more women to participate in regular breast cancer screenings, thereby driving market growth.

Challenges in the digital breast tomosynthesis equipment market are:

• High Cost of Equipment: The high cost of digital breast tomosynthesis equipment remains a significant challenge for market growth. Advanced imaging technologies and sophisticated features contribute to the high price of digital breast tomosynthesis systems, which can be a barrier to adoption, particularly in smaller healthcare facilities or emerging markets. The substantial investment required for purchasing and maintaining digital breast tomosynthesis equipment may limit access and slow down the widespread adoption of these advanced systems. Addressing cost concerns and developing more cost-effective solutions are crucial for overcoming this challenge.
• Integration with Existing Systems: Integrating digital breast tomosynthesis systems with existing imaging infrastructure and electronic health records (EHR) can be complex and challenging. Compatibility issues between new digital breast tomosynthesis technologies and legacy systems may require additional investments in software and hardware upgrades. Effective integration is essential for ensuring smooth workflows and accurate data sharing. Overcoming these integration challenges involves addressing technical and operational hurdles to facilitate the seamless adoption and utilization of digital breast tomosynthesis systems in diverse healthcare settings.
• Regulatory and Compliance Issues: Navigating regulatory requirements and compliance issues is a significant challenge in the digital breast tomosynthesis market. Different countries have varying regulations regarding medical devices, which can impact the approval and marketing of digital breast tomosynthesis systems. Ensuring that digital breast tomosynthesis equipment meets rigorous standards for safety, effectiveness, and performance is critical but can be time-consuming and costly. Manufacturers must stay updated with regulatory changes and work closely with regulatory bodies to streamline the approval process and facilitate market entry.

The digital breast tomosynthesis equipment market is influenced by technological advancements, increasing demand for early detection, supportive government initiatives, AI integration, and a focus on patient comfort. However, challenges such as high equipment costs, integration issues, and regulatory hurdles need to be addressed. Understanding these drivers and challenges is essential for stakeholders to navigate the market effectively and leverage opportunities for growth while overcoming potential obstacles.

List of Digital Breast Tomosynthesis Equipment Companies

Companies in the market compete based on product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies, digital breast tomosynthesis equipment companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the digital breast tomosynthesis equipment companies profiled in this report include-

• Hologic
• GE Healthcare
• Siemens Healthineers
• Dexela
• Fujifilm
• Planmed OY
• Trivitron Healthcare

Digital Breast Tomosynthesis Equipment by Segment

The study includes a forecast for the global digital breast tomosynthesis equipment market by product type, end use, and region.

Digital Breast Tomosynthesis Equipment Market by Product Type [Analysis by Value from 2019 to 2031]:

• Equipment
• Upgradation

Digital Breast Tomosynthesis Equipment Market by End Use [Analysis by Value from 2019 to 2031]:

• Hospitals
• Diagnostic Centers
• Others

Digital Breast Tomosynthesis Equipment Market by Region [Analysis by Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Digital Breast Tomosynthesis Equipment Market

Recent developments in the digital breast tomosynthesis equipment market reflect advancements in technology and increasing adoption across various regions. Digital breast tomosynthesis, an advanced form of 3D mammography, is enhancing early breast cancer detection and diagnostic accuracy. As technology evolves, the market is experiencing significant growth driven by innovations in imaging technology, regulatory approvals, and shifts in clinical practice. Key developments in the United States, China, Germany, India, and Japan highlight these trends and demonstrate how different countries are advancing in the adoption and implementation of DBT technologies.

• United States: In the United States, recent developments in the digital breast tomosynthesis market include the introduction of more advanced digital breast tomosynthesis systems with higher resolution and faster imaging capabilities. Major players, such as Hologic and Siemens Healthineers, have launched new digital breast tomosynthesis models featuring improved contrast and reduced radiation doses. Enhanced artificial intelligence (AI) integration is also a notable trend, offering better image analysis and aiding in early cancer detection. The adoption of digital breast tomosynthesis is growing rapidly in both private and public healthcare settings, supported by favorable reimbursement policies and increasing awareness of its benefits in breast cancer screening and diagnosis.
• China: China is seeing significant progress in the digital breast tomosynthesis market with an increase in domestic production and adoption of digital breast tomosynthesis technology. Chinese companies are developing cost-effective digital breast tomosynthesis systems to meet the needs of the expanding healthcare sector. Recent developments include partnerships between local firms and international technology providers to enhance the quality and affordability of digital breast tomosynthesis equipment. Additionally, there has been a push for upgrading existing mammography units to incorporate digital breast tomosynthesis capabilities. The growing focus on early breast cancer detection, coupled with government support for advanced medical technologies, is driving the market expansion in China.
• Germany: Germany has made notable strides in the digital breast tomosynthesis market with advancements in both technology and clinical application. Recent developments include the introduction of digital breast tomosynthesis systems that offer improved image quality and more efficient workflow integration for radiologists. German hospitals and research institutions are increasingly adopting digital breast tomosynthesis technology to enhance diagnostic accuracy and patient outcomes. The country is also witnessing innovations in hybrid imaging systems that combine digital breast tomosynthesis with other modalities, such as ultrasound, for comprehensive breast imaging. Supportive regulatory frameworks and investment in healthcare infrastructure are contributing to the growth and adoption of digital breast tomosynthesis equipment in Germany.
• India: In India, the digital breast tomosynthesis market is expanding as more healthcare facilities invest in advanced imaging technologies. Recent developments include the entry of new players offering affordable digital breast tomosynthesis systems tailored to the Indian market. The Indian government and private sector are increasingly recognizing the importance of early breast cancer detection, leading to increased installations of digital breast tomosynthesis equipment across various regions. There is also a growing focus on training healthcare professionals to effectively utilize digital breast tomosynthesis technology. Despite challenges such as cost and infrastructure limitations, the market is poised for growth driven by increasing awareness and demand for advanced diagnostic tools.
• Japan: Japan is experiencing significant developments in the digital breast tomosynthesis market, driven by technological advancements and high healthcare standards. Recent progress includes the introduction of digital breast tomosynthesis systems with enhanced imaging capabilities and integration with digital health records for improved patient management. Japanese companies are focusing on innovation and precision, developing digital breast tomosynthesis equipment that supports early breast cancer detection with minimal discomfort for patients. The adoption of digital breast tomosynthesis is supported by strong regulatory frameworks and a high level of investment in medical technology. Japan's emphasis on advanced imaging solutions and early diagnosis is fostering the growth of the digital breast tomosynthesis market.

Features of the Global Digital Breast Tomosynthesis Equipment Market

Market Size Estimates: Digital breast tomosynthesis equipment market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.

Segmentation Analysis: Digital breast tomosynthesis equipment market size by product type, end use, and region in terms of value ($B).

Regional Analysis: Digital breast tomosynthesis equipment market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product types, end uses, and regions for the digital breast tomosynthesis equipment market.

Strategic Analysis: This includes M&A, new product development, and the competitive landscape of the digital breast tomosynthesis equipment market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers the following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the digital breast tomosynthesis equipment market by product type (equipment and upgradation), end use (hospitals, diagnostic centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Digital Breast Tomosynthesis Equipment Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

• 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
• 3.2. Global Digital Breast Tomosynthesis Equipment Market Trends (2019-2024) and Forecast (2025-2031)
• 3.3: Global Digital Breast Tomosynthesis Equipment Market by Product Type
  • 3.3.1: Equipment
  • 3.3.2: Upgradation
• 3.4: Global Digital Breast Tomosynthesis Equipment Market by End Use
  • 3.4.1: Hospitals
  • 3.4.2: Diagnostic Centers
  • 3.4.3: Others

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

• 4.1: Global Digital Breast Tomosynthesis Equipment Market by Region
• 4.2: North American Digital Breast Tomosynthesis Equipment Market
  • 4.2.1: North American Market by Product Type: Equipment and Upgradation
  • 4.2.2: North American Market by End Use: Hospitals, Diagnostic Centers, and Others
• 4.3: European Digital Breast Tomosynthesis Equipment Market
  • 4.3.1: European Market by Product Type: Equipment and Upgradation
  • 4.3.2: European Market by End Use: Hospitals, Diagnostic Centers, and Others
• 4.4: APAC Digital Breast Tomosynthesis Equipment Market
  • 4.4.1: APAC Market by Product Type: Equipment and Upgradation
  • 4.4.2: APAC Market by End Use: Hospitals, Diagnostic Centers, and Others
• 4.5: ROW Digital Breast Tomosynthesis Equipment Market
  • 4.5.1: ROW Market by Product Type: Equipment and Upgradation
  • 4.5.2: ROW Market by End Use: Hospitals, Diagnostic Centers, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Digital Breast Tomosynthesis Equipment Market by Product Type
  • 6.1.2: Growth Opportunities for the Global Digital Breast Tomosynthesis Equipment Market by End Use
  • 6.1.3: Growth Opportunities for the Global Digital Breast Tomosynthesis Equipment Market by Region
• 6.2: Emerging Trends in the Global Digital Breast Tomosynthesis Equipment Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Digital Breast Tomosynthesis Equipment Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Digital Breast Tomosynthesis Equipment Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Hologic
• 7.2: GE Healthcare
• 7.3: Siemens Healthineers
• 7.4: Dexela
• 7.5: Fujifilm
• 7.6: Planmed OY
• 7.7: Trivitron Healthcare